Recombinant AAV vector packaging self-complementary myr-AKT1 under the CAG promoter.
![]() Drawn by SnapGene® software |
|
| Clone info. | Recombinant AAV vector packaging self-complementary myr-AKT1 (myristoylated Akt1) under the CAG promoter. |
|---|---|
| Comment | The integrity of ITR (positions 21-142) must be confirmed by restriction digestion. For example, when using XhoI and NcoI, the correct fragment length is 422 bp, whereas the loss of the ITR results in a 326 bp fragment. |
| Vector backbone | pscAAV-CAG-GFP (plasmid) |
| Selectable markers | Ampicillin (E. coli) |
| Gene/insert name | mouse Akt1 cDNA; synthetic N-myristoylation signal. |
| Depositor|Developer | Ikawa, Masahito | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (Takehiro Hiraoka et al. Nat. Commun., Jul 1;16(1):5755. doi: 10.1038/s41467-025-60610-x. 2025) The RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with The University of Osaka(mta-egr@biken.osaka-u.ac.jp). Additional terms and conditions: The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. |
| Remarks | Remember that you will be working with samples containing infectious virus. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Takehiro Hiraoka et al. Nat. Commun., Jul 1;16(1):5755. doi: 10.1038/s41467-025-60610-x. 2025)。利用者が非営利目的の教育・研究以外の目的に用いる場合は、大阪大学(mta-egr@biken.osaka-u.ac.jp)と別途MTAを締結すること。 付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。 |
| 備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB20988 | pscAAV-CAG-myr-AKT1 | DNA solution |
Materials & Methods section:
| The pscAAV-CAG-myr-AKT1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB20988). |
Reference section:
| Hiraoka, T., Aikawa, S., Mashiko, D., Nakagawa, T., Shirai, H., Hirota, Y., Kimura, H., Ikawa, M., An ex vivo uterine system captures implantation, embryogenesis, and trophoblast invasion via maternal-embryonic signaling. Nat. Commun. 16 (1): 5755 (2025). PMID 40595542. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Hiraoka, T., An ex vivo uterine system captures implantation, embryogenesis, and trophoblast invasion via maternal-embryonic signaling. Nat. Commun. 16 (1): 5755 (2025). PMID 40595542. [PubMed] [Article] [RRC of NBRP] |
|---|
Featured content